Open AccessHow long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice
Author(s) -
Aldo Franco De Rose,
Francesco Vecco,
Francesca Ambrosini,
Rafaela Malinaric,
Guglielmo Mantica,
Carlo Terrone
Publication year - 2022
Publication title -
archivio italiano di urologia andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 23
eISSN - 2282-4197
pISSN - 1124-3562
DOI - 10.4081/aiua.2022.3.369
Subject(s) - bladder cancer , clinical practice , medicine , general surgery , cancer , intensive care medicine , physical therapy
To the Editor, The exact time to stop bladder cancer patient's follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].